Distribution of four HIV type 1-resistance polymorphisms (CCR5-Δ32, CCR5-m303, CCR2-64I, and SDF1-3′A) in the Bahraini population

AIDS Research and Human Retroviruses

Volumn 25, Issue 10, 2009, Pages 973-977

  Salem, Abdel Halim ^a   Farid, Eman ^a   Fadel, Raouf ^a   Abu Hijleh, Marwan ^a   Almawi, Wassim ^a   Han, Kyudong ^b   Batzer, Mark A ^b  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; STROMAL CELL DERIVED FACTOR 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; BAHRAIN; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS RESISTANCE;

BAHRAIN; CHEMOKINE CXCL12; GENE FREQUENCY; HIV INFECTIONS; HUMANS; IMMUNITY, INNATE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CCR2; RECEPTORS, CCR5;

EID: 70449461404     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0066     Document Type: Article

References (46)

1. Alkhatib G, Combadiere C, Broder CC, et al.: CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
2. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNAcloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877. (Pubitemid 26154590)
3. Mummidi S, Ahuja SS, Gonzalez E, et al.: Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998;4:786-793.
4. Littman DR: Chemokine receptors: Keys to AIDS pathogenesis? Cell 1998;93:677-680.
5. Bleul CC, Farzan M, Choe H, et al.: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR=fusin and blocks HIV-1 entry. Nature 1996;382:829-833.
6. Huang Y, Paxton WA, Wolinsky SM, et al.: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-1243.
7. Fauci AS: Resistance to HIV-1 infection: It's in the genes. Nat Med 1996;2:966-967.
8. Smith MW, Dean M, Carrington M, et al.: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 1997;277:959-965.
9. Dean M, Carrington M, Winkler C, et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-1862.
10. Carrington M, Nelson GW, Martin MP, et al.: HLA and HIV-1: Heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999;283:1748-1752.
11. Carrington M, Kissner T, Gerrard B, Ivanov S, O'Brien SJ, and Dean M: Novel alleles of the chemokine-receptor gene CCR5. Am J Hum Genet 1997;61:1261-1267.
12. Winkler C, Modi W, Smith MW, et al.: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-393.
13. Dezzutti CS, Guenthner PC, Green TA, Cohen OJ, Spira TJ, and Lal RB: Stromal-derived factor-1 chemokine gene variant is associated with the delay of HIV-1 disease progression in two longitudinal cohorts. AIDS 2000;14:894-896.
14. Ioannidis JP, Rosenberg PS, Goedert JJ, et al.: Effects of CCR5-Delta32, CCR2-64I, and SDF-1 30A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data. Ann Intern Med 2001;135:782-795.
15. Liu R, Paxton WA, Choe S, et al.: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell 1996;86:367-377.
16. Samson M, Libert F, Doranz BJ, et al.: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996;382:722-725.
17. Martinson JJ, Chapman NH, Rees DC, Liu YT, and Clegg JB: Global distribution of the CCR5 gene 32-basepair deletion. Nat Genet 1997;16:100-103.
18. Voevodin A, Samilchuk E, and Dashti S: A survey for 32 nucleotide deletion in the CCR-5 chemokine receptor gene (deltaccr-5) conferring resistance to human immunodeficiency virus type 1 in different ethnic groups and in chimpanzees. J Med Virol 1998;55:147-151. (Pubitemid 28221619)
19. Voevodin A, Samilchuk E, and Dashti S: The frequency of delta-ccr5 mutation in Arabs, Asians and Russians. J Mol Med 1997;75:B179-B180.
20. Mummidi S, Ahuja SS, McDaniel BL, and Ahuja SK: The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 50-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J Biol Chem 1997;272:30662-30671.
21. Su B, Jin L, Hu F, et al.: Distribution of two HIV-1-resistant polymorphisms (SDF1-30A and CCR2-64I) in East Asian and world populations and its implication in AIDS epidemiology. Am J Hum Genet 1999;65:1047-1053.
22. Su B, Sun G, Lu D, et al.: Distribution of three HIV-1 resistance-conferring polymorphisms (SDF1-30A, CCR2-641, and CCR5-delta32) in global populations. Eur J Hum Genet 2000;8:975-979.
23. Martinson JJ, Hong L, Karanicolas R, Moore JP, and Kostrikis LG: Global distribution of the CCR2-64I=CCR5-59653T HIV-1 disease-protective haplotype. AIDS 2000;14:483-489.
24. Diaz FJ, Vega JA, Patino PJ, et al.: Frequency of CCR5 delta-32 mutation in human immunodeficiency virus (HIV)-seropositive and HIV-exposed seronegative individuals and in general population of Medellin, Colombia. Mem Inst Oswaldo Cruz 2000;95:237-242.
25. Voevodin A, Samilchuk E, and Dashti S: Frequencies of SDF-1 chemokine, CCR-5, and CCR-2 chemokine receptor gene alleles conferring resistance to human immunodeficiency virus type 1 and AIDS in Kuwaitis. J Med Virol 1999;58:54-58.
26. Excoffier L, Laval G, and Schneider S: Arlequin ver. 3.0: An integrated software package for population genetics data analysis. Evol Bioinform Online 2005;1:47-50.
27. Snedecor GW and Cochran WG: Statistical Methods. Iowa State University Press, Ames, IA, 1976.
28. Hutcheson HB, Lautenberger JA, Nelson GW, et al.: Detecting AIDS restriction genes: From candidate genes to genomewide association discovery. Vaccine 2008;26:2951-2965.
29. Quillent C, Oberlin E, Braun J, et al.: HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene. Lancet 1998;351:14-18.
30. Mellado M, Rodriguez-Frade JM, Vila-Coro AJ, de Ana AM, and Martinez AC: Chemokine control of HIV-1 infection. Nature 1999;400:723-724.
31. Berger EA, Murphy PM, and Farber JM: Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease. Annu Rev Immunol 1999;17:657-700.
32. Su B, Chakraborty R, Jin L, Xiao J, and Lu D: An HIVresistant allele is exceptionally frequent in New Guinean highlanders. JAMA 1998;280:1830.
33. Qian Y, Sun H, Lin K, Shi L, and Chu J: Distribution of CCR5-Delta32, CCR2-64I, SDF1-3'A, CX3CR1-249I, and CX3CR1-280M in Chinese populations. AIDS Res Hum Retroviruses 2008;24:1391-1397.
34. Christodoulou C, Poullikas M, Neumann AU, and Kostrikis LG: Low frequency of CCR5delta32 allele among Greeks in Cyprus. AIDS Res Hum Retroviruses 1997;13:1373-1374.
35. Libert F, Cochaux P, Beckman G, et al.: The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet 1998;7:399-406.
36. Guo SW and Thompson EA: Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361-372.
37. Barbouche RM, Hong L, Dellagi K, and Kostrikis LG: Contrasting frequencies of CCR5delta32 and CCR2-64I alleles in the Tunisian population. J Acquir Immune Defic Syndr 2001;26:298-299.
38. Alvarez V, Lopez-Larrea C, and Coto E: Mutational analysis of the CCR5 and CXCR4 genes (HIV-1 co-receptors) in resistance to HIV-1 infection and AIDS development among intravenous drug users. Hum Genet 1998;102:483-486.
39. Lewandowska M, Franciszkiewicz K, Prokop J, Ofori H, and Jagodzinski PP: Distribution of two HIV-1-resistant polymorphisms (SDF1-30A and CCR2-64I alleles) in the Polish population. J Hum Genet 2002;47:585-589.
40. Romano-Spica V, Ianni A, Arzani D, Cattarini L, Majore S, and Dean M: Allelic distribution of CCR5 and CCR2 genes in an Italian population sample. AIDS Res Hum Retroviruses 2000;16:99-101.
41. Ryabov GS, Kazennova EV, Bobkova MR, and Bobkov AF: Prevalence of alleles associated with HIV resistance in Russia. Genet Test 2004;8:73-76.
42. Apostolakis S, Baritaki S, Krambovitis E, and Spandidos DA: Distribution of HIV=AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population. J Clin Virol 2005; 34:310-314.
43. Verma R, Gupta RB, Singh K, et al.: Distribution of CCR5delta32, CCR2-64I and SDF1-30A and plasma levels of SDF-1 in HIV-1 seronegative North Indians. J Clin Virol 2007;38:198-203.
44. Ikegawa M, Yuan J, Matsumoto K, et al.: Elevated plasma stromal cell-derived factor 1 protein level in the progression of HIV type 1 infection=AIDS. AIDS Res Hum Retroviruses 2001;17:587-595.
45. Salem AH and Batzer MA: Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians. Mutat Res 2007;616:175-180.
46. Gharagozloo M, Doroudchi M, Farjadian S, Pezeshki AM, and Ghaderi A: The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population. Immunol Lett 2005;96:277-281.